Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAz7s2DG7q5YHxAe4acqg90lZufNiFPCHCSadN7U3mUWY#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "sutent is a kinase inhibitor indicated for the treatment of gastrointestinal stromal tumor gist after disease progression on or intolerance to imatinib mesylate 1 1 the treatment of advanced renal cell carcinoma rcc 1 2 the adjuvant treatment of adult patients at high risk of recurrent rcc following nephrectomy 1 3 the treatment of progressive well differentiated pancreatic neuroendocrine tumors pnet in patients with unresectable locally advanced or metastatic disease 1 4 sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate sutent is indicated for the treatment of advanced renal cell carcinoma sutent is indicated for the adjuvant treatment of adult patients at high risk of recurrent rcc following nephrectomy sutent is indicated for the treatment of progressive well differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease" assertion.
- association object DOID_4450 assertion.
- association predicate treats assertion.
- association subject drugbank:DB01268 assertion.
- association relation TreatmentIndication assertion.
- DOID_4450 category Disease assertion.
- drugbank:DB01268 category Drug assertion.
- association provided_by NeuroDKG assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.